271 related articles for article (PubMed ID: 18162777)
21. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
22. Regeneration in zebrafish lateral line neuromasts: expression of the neural progenitor cell marker sox2 and proliferation-dependent and-independent mechanisms of hair cell renewal.
Hernández PP; Olivari FA; Sarrazin AF; Sandoval PC; Allende ML
Dev Neurobiol; 2007 Apr; 67(5):637-54. PubMed ID: 17443814
[TBL] [Abstract][Full Text] [Related]
23. Expression of nestin mRNA is a differentiation marker in thyroid tumors.
Yamada H; Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Watanabe M; Iwatani Y; Miyauchi A
Cancer Lett; 2009 Jul; 280(1):61-4. PubMed ID: 19268442
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
25. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
26. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
[TBL] [Abstract][Full Text] [Related]
27. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
[TBL] [Abstract][Full Text] [Related]
28. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
29. [Differentiation in primitive neuroectodermal tumors. Significance of histology and immunohistochemistry for differential diagnosis].
Grieshammer T
Zentralbl Pathol; 1991; 137(1):57-65. PubMed ID: 1647814
[TBL] [Abstract][Full Text] [Related]
30. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity.
Dráberová E; Del Valle L; Gordon J; Marková V; Smejkalová B; Bertrand L; de Chadarévian JP; Agamanolis DP; Legido A; Khalili K; Dráber P; Katsetos CD
J Neuropathol Exp Neurol; 2008 Apr; 67(4):341-54. PubMed ID: 18379434
[TBL] [Abstract][Full Text] [Related]
31. Dynamic Sox5 protein expression during cranial ganglia development.
Morales AV; Perez-Alcala S; Barbas JA
Dev Dyn; 2007 Sep; 236(9):2702-7. PubMed ID: 17685482
[TBL] [Abstract][Full Text] [Related]
32. Consequence of the loss of Sox2 in the developing brain of the mouse.
Miyagi S; Masui S; Niwa H; Saito T; Shimazaki T; Okano H; Nishimoto M; Muramatsu M; Iwama A; Okuda A
FEBS Lett; 2008 Aug; 582(18):2811-5. PubMed ID: 18638478
[TBL] [Abstract][Full Text] [Related]
33. Expression of Sox2 in mouse taste buds and its relation to innervation.
Suzuki Y
Cell Tissue Res; 2008 Jun; 332(3):393-401. PubMed ID: 18379823
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic modifications of SOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation.
Sikorska M; Sandhu JK; Deb-Rinker P; Jezierski A; Leblanc J; Charlebois C; Ribecco-Lutkiewicz M; Bani-Yaghoub M; Walker PR
J Neurosci Res; 2008 Jun; 86(8):1680-93. PubMed ID: 18293417
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study.
Rodriguez FJ; Scheithauer BW; Roncaroli F; Silva AI; Kovacs K; Brat DJ; Jin L
Am J Surg Pathol; 2008 Sep; 32(9):1344-52. PubMed ID: 18670355
[TBL] [Abstract][Full Text] [Related]
36. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
37. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
38. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
39. Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants.
Cavallaro M; Mariani J; Lancini C; Latorre E; Caccia R; Gullo F; Valotta M; DeBiasi S; Spinardi L; Ronchi A; Wanke E; Brunelli S; Favaro R; Ottolenghi S; Nicolis SK
Development; 2008 Feb; 135(3):541-57. PubMed ID: 18171687
[TBL] [Abstract][Full Text] [Related]
40. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
